Vivesto Toekomstige groei
Future criteriumcontroles 0/6
Vivesto's revenue is forecast to decline at 122.1% per annum while its annual earnings are expected to grow at 29.6% per year. EPS is expected to grow by 30.8% per annum.
Belangrijke informatie
29.6%
Groei van de winst
30.8%
Groei van de winst per aandeel
| Biotechs winstgroei | 48.4% |
| Inkomstengroei | -122.1% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 26 Aug 2024 |
Recente toekomstige groei-updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -45 | -42 | -42 | 1 |
| 12/31/2025 | N/A | -37 | -33 | -33 | 1 |
| 12/31/2024 | N/A | -39 | -48 | -48 | 1 |
| 6/30/2024 | 7 | -99 | -54 | -53 | N/A |
| 3/31/2024 | 7 | -117 | -62 | -62 | N/A |
| 12/31/2023 | 7 | -129 | -69 | -69 | N/A |
| 9/30/2023 | 2 | -284 | -88 | -87 | N/A |
| 6/30/2023 | 3 | -340 | -92 | -91 | N/A |
| 3/31/2023 | 3 | -351 | -89 | -88 | N/A |
| 12/31/2022 | 3 | -357 | -86 | -86 | N/A |
| 9/30/2022 | 13 | -140 | -105 | -104 | N/A |
| 6/30/2022 | 24 | -99 | -107 | -107 | N/A |
| 3/31/2022 | 29 | -118 | -134 | -133 | N/A |
| 12/31/2021 | 29 | -133 | -180 | -146 | N/A |
| 9/30/2021 | -184 | -348 | -358 | -324 | N/A |
| 6/30/2021 | -195 | -354 | -378 | -341 | N/A |
| 3/31/2021 | -199 | -376 | -216 | -178 | N/A |
| 12/31/2020 | 4 | -210 | -211 | -205 | N/A |
| 10/31/2020 | 205 | -59 | -19 | -11 | N/A |
| 7/31/2020 | 205 | -24 | -56 | -47 | N/A |
| 4/30/2020 | 206 | -11 | -19 | -7 | N/A |
| 1/31/2020 | 4 | -196 | -198 | -187 | N/A |
| 10/31/2019 | 6 | -167 | -181 | -168 | N/A |
| 7/31/2019 | 9 | -210 | -150 | -134 | N/A |
| 4/30/2019 | 10 | -201 | -131 | -119 | N/A |
| 1/31/2019 | 14 | -154 | -118 | -104 | N/A |
| 10/31/2018 | 13 | -153 | -122 | -97 | N/A |
| 7/31/2018 | 13 | -117 | -124 | -103 | N/A |
| 4/30/2018 | 12 | -118 | N/A | -124 | N/A |
| 1/31/2018 | 10 | -128 | N/A | -124 | N/A |
| 10/31/2017 | 10 | -139 | N/A | -144 | N/A |
| 7/31/2017 | 8 | -155 | N/A | -134 | N/A |
| 4/30/2017 | 7 | -160 | N/A | -133 | N/A |
| 1/31/2017 | 7 | -151 | N/A | -145 | N/A |
| 10/31/2016 | 16 | -137 | N/A | -147 | N/A |
| 7/31/2016 | 19 | -139 | N/A | -142 | N/A |
| 4/30/2016 | 23 | -142 | N/A | -128 | N/A |
| 1/31/2016 | 26 | -139 | N/A | -112 | N/A |
| 10/31/2015 | 18 | -141 | N/A | -93 | N/A |
| 7/31/2015 | 19 | -124 | N/A | -101 | N/A |
| 4/30/2015 | 19 | -117 | N/A | -108 | N/A |
| 1/31/2015 | 23 | -125 | N/A | -109 | N/A |
| 10/31/2014 | 26 | -128 | N/A | -108 | N/A |
| 7/31/2014 | 28 | -120 | N/A | -102 | N/A |
| 4/30/2014 | 30 | -105 | N/A | -87 | N/A |
| 1/31/2014 | 30 | -90 | N/A | -81 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: VIVE is forecast to remain unprofitable over the next 3 years.
Winst versus markt: VIVE is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: VIVE is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: VIVE is forecast to have no revenue next year.
Hoge groei-inkomsten: VIVE is forecast to have no revenue next year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if VIVE's Return on Equity is forecast to be high in 3 years time